Healius Limited (PGZ) AI Stock Analysis

2 Followers

Healius Limited

(Frankfurt:PGZ)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Persistent Cash GenerationPersistent positive operating and free cash flow show that Healius continues converting diagnostic activity into liquidity despite accounting losses. This supports debt reduction, ongoing operations, and selective investment, providing a durable financial buffer over the next several quarters.

Negative Factors

Persistent Net LossesFour consecutive years of net losses indicate that revenue recovery has not yet translated into durable shareholder earnings. Continued losses can restrict reinvestment, weaken equity, and leave the company more dependent on operating cash flow to support obligations and strategic initiatives.

Healius Limited (PGZ) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 237.52M
Dividend Yield: ―
Average Volume (3M): 2,797
Price to Earnings (P/E): -0.9
Beta (1Y): 0.85
Revenue Growth: -0.16%
EPS Growth: 18.64%
Country: Germany
Employees: 6,000
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Diagnostics & Research

Healius Limited Business Overview & Revenue Model

Company Description

Healius Limited is an Australian firm dedicated to delivering specialized diagnostic services to both individual consumers and healthcare practitioners. Its operations are structured into four primary segments: Pathology, Medical Imaging, Day Hospita...

Healius Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:PGZ against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AU:SHL	72Outperform	AUD 9.83B	16.17	7.20%	5.45%	14.40%	15.11%
AU:ACL	54Neutral	AUD 606.19M	26.66	15.80%	3.92%	-0.90%	-25.09%
AU:MVF	54Neutral	AUD 292.23M	40.58	2.95%	3.25%	-0.90%	-70.25%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
AU:IDX	48Neutral	AUD 640.52M	28.83	3.24%	5.88%	25.73%	390.83%
AU:LDX	44Neutral	AUD 69.17M	-7.47	-35.89%	―	1.36%	39.13%

* Healthcare Sector Average

Performance Comparison

DE:PGZ and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:PGZ	Healius Limited	0.31	-0.18	-36.33%
AU:LDX	Lumos Diagnostics Holdings Ltd.	0.07	-0.13	-63.50%
AU:SHL	Sonic Healthcare Limited	19.83	-0.36	-1.76%
AU:IDX	Integral Diagnostics Ltd.	1.70	-0.76	-30.89%
AU:ACL	Australian Clinical Labs Ltd	3.32	0.76	29.94%
AU:MVF	Monash IVF Group Ltd	0.77	0.19	31.85%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Healius Limited AI Stock Analysis